| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |